Investigation of the actoprotective properties of the tripeptide Pinealon
Animal research · 2015
- What was studied
- 24 five-month-old male outbred rats (250–300 g), four groups; three treadmill groups and one vivarium control
- Main finding
- Treadmill time improved in all training arms. The authors report day-10 increases of 18 minutes with Pinealon and 13.8 minutes with Metaprot relative to their own baselines.
Pinealon · treadmill time · Day 3 +8.7 min; day 5 +13.2 min; day 10 +18 min · Reported as 175%, 214% and 254% of its baseline, respectively. The paper reports persistence for three days after stopping.
Related evidence maps: Sports performance ↗
Reported findings and study design
24 male rats; vivarium control, trained control, Metaprot and Pinealon. Daily treadmill to exhaustion.
Population or model 24 five-month-old male outbred rats (250–300 g), four groups; three treadmill groups and one vivarium control
Dose, route and schedule
Pinealon T-33 75 µg/kg or Metaprot 25 mg/kg intraperitoneally, 10 treatment days with a 2-day interval after day 5. Daily treadmill testing at 35 m/min; trained control received no drug.
Protocol source ↗ · Original publisher PDF methods
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| Pinealon · treadmill time | Day 3 +8.7 min; day 5 +13.2 min; day 10 +18 min | Reported as 175%, 214% and 254% of its baseline, respectively. The paper reports persistence for three days after stopping. |
| Metaprot · treadmill time | Day 5 +8.4 min; day 10 +13.8 min | Within-arm baseline comparisons. The authors report a decline to about 10 min on day 11 after cessation. |
| Training effect | All three treadmill groups improved during training | The paper attributes some early improvement to training. Baseline-relative changes do not establish a between-drug effect. |
| Pinealon · hemoglobin | 158.2±8.8 → 128.6±4.3 g/L | Baseline to day 10; marked p≤0.01 versus own baseline. Trained control: 137.0±3.8 → 158.0±8.2 g/L. |
| Pinealon · erythrocytes | 8.8±0.6 → 7.0±0.5 million/µL | Baseline to day 10; marked p≤0.05 versus own baseline. The decrease is a separate finding, not established as beneficial. |
Table 1 · selected hematology values (M±m)
| Group, measure | Baseline | Day 5 | Day 10 |
|---|---|---|---|
| Pinealon · leukocytes (thousands/µL) | 14.6±1.2 | 8.4±1.2** | 10.2±1.3* |
| Pinealon · erythrocytes (millions/µL) | 8.8±0.6 | 8.4±0.3 | 7.0±0.5* |
| Pinealon · hemoglobin (g/L) | 158.2±8.8 | 144.7±7.0 | 128.6±4.3** |
| Pinealon · platelets (thousands/µL) | 847±103 | 789±111 | 575±120 |
| Trained control · hemoglobin (g/L) | 137.0±3.8 | 142.0±8.5 | 158.0±8.2** |
| Metaprot · hemoglobin (g/L) | 166.8±11.7 | 139.2±12.6 | 150.8±8.4 |
* p≤0.05; ** p≤0.01 relative to each group’s own baseline. No between-arm statistical test inferred.
The treadmill study documents an animal training experiment. Different starting values, small groups and mixed hematology limit any comparative performance claim.
Source for these results ↗ · Reviewed 2026-11-08
Study limitations and source details
Study limitations
- Animal endurance is not human cognitive performance, sleep, or occupational safety.
- No numerical effect estimate is entered before table-level review.
- The original PDF identifies issue 2(38); some later bibliographies give conflicting issue numbers.
Source details
Original 7-page PDF, methods, treadmill narrative and selected hematology values checked.
Sources checked
Citation
G. S. Belyaeva, O. K. Davydova, A. I. Erofeev, V. A. Maydan, G. A. Ryzhak, T. V. Siretskaya, V. Kh. Khavinson. Investigation of the actoprotective properties of the tripeptide Pinealon Biotekhnosfera. 2(38):25–31
Related compounds
Pinealon
A synthetic tripeptide, Glu–Asp–Arg (EDR). Researchers have examined its effects in neuronal aging models and measured functional outcomes in human performance studies.
Bemitil
A synthetic benzimidazole derivative also called bemethyl or Metaprot. Soviet and Russian researchers studied it as an actoprotector, a drug intended to preserve physical work capacity under stress.